On heels of MariTide data, Danish obesity biotech discloses €80M Series A

Versant is out with its third obesity biotech of the year, leading an €80 million Series A for Antag Therapeutics, a Danish company developing a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

First-Ever Biologic Approved for COPD

The FDA approved dupilumab (Dupixent) as the first biologic treatment for adults with chronic obstructive pulmonary disease (COPD), Sanofi and Regeneron announced on Friday. An

September 28, 2024

Evolva and Nice & Green agree on improvements to financing agreement – Biotech Investments

Evolva Holding SA / Key word(s): Agreement 13-Sep-2023 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is

September 14, 2023

NHS to provide vision-saving drug to premature babies

Ranibizumab is claimed to aid in saving the eyesight of babies with ROP. Credit: Picsea on Unsplash. The UK National Health Service (NHS) has announced

July 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.